Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars

Inclusion criteria

• Is a healthy male or female between 18 and 85 years old.
• Has unwanted scars (including atrophic, hypertrophic, hyper or hypo pigmented, erythematous )and wishes to undergo laser treatments to remove or improve them.
• Is willing to consent to participate in the study.
• Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits

Exclusion criteria

• Is hypersensitive to light exposure.
• Has active localized or systemic infection.
• Is taking medication(s) for which sunlight is a contraindication.
• Has a history of squamous cell carcinoma or melanoma.
• Has a history of keloid scarring.
• Has used oral isotretinoin (Accutane®) within 12 months of initial treatment or plans on using during the course of the study. Note: Skin must regain its normal degree of moisture prior to treatment.
• Has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications.
• Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period.
• Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine.
• Has any other reason determined by the physician to be ineligible to participate in the study.